The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
2014; BioMed Central; Volume: 14; Issue: 1 Linguagem: Inglês
10.1186/s12913-014-0676-0
ISSN1472-6963
AutoresMirko Sikirica, Şerban R. Iorga, Tim Bancroft, Jesse Potash,
Tópico(s)Cardiovascular Issues in Pregnancy
ResumoPulmonary arterial hypertension (PAH) is a rare condition that can ultimately lead to right heart failure and death. In this study we estimated the health care costs and resource utilization associated with PAH in a large US managed care health plan.
Referência(s)